Will symptomatic intracerebral hemorrhages decrease among eligible dabigatran-treated patients who receive intravenous tissue plasminogen activator for acute ischemic stroke?

Lung Chan

Research output: Contribution to journal › Letter › peer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Will symptomatic intracerebral hemorrhages decrease among eligible dabigatran-treated patients who receive intravenous tissue plasminogen activator for acute ischemic stroke?'. Together they form a unique fingerprint.